European Medicines Agency accepts marketing authorization application for etripamil nasal spray in PSVT – Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc. announced the acceptance of a Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) seeking the approval of etripamil nasal spray, developed to be the… read more.
